Cephalothin in Serious Bacterial Infection

Publisher Website
Google Scholar
Abstract
Details of 77 treatment courses of cephalothin for serious infections such as pneumonia and bacteremia due to Staphylococcus aureus, other Gram-positive cocci and various Gram-negative bacilli are presented. The clinical and bacteriologic responses were considered to be excellent on the whole. The mortality related to infection was 27% in the cases analyzed; inclusion of 8 additional critically ill patients who died with 48 hours would raise the mortality to 38%. Seven instances of clinically significant superinfection occurred. Side effects, seen in 24 patients, were not of a serious nature and were not dose related. The possibility that there may be cross allergenicity between cephalothin and the penicillins is discussed.

This publication has 9 references indexed in Scilit: